Back to search results

Youth Emotional and Behavioral Treatment Study for Depression and Anxiety

This study is looking at how Cognitive Behavioral Therapy (a type of talk therapy that helps you change thinking patterns and behaviors) can help young people aged 4 to 17 who are experiencing depression or anxiety. We want to understand what causes these emotional difficulties and how treatment helps. The study will measure improvements in your child's overall condition and how they react emotionally over a period of up to 28 weeks. To join, your child needs to be between 4 and 17 years old and have a diagnosis of an anxiety or mood disorder, or parents report significant irritability or disruptive behavior. Both the child and parent must be able to complete study activities in English. The current status of this study is unclear.

Study design
This interventional study plans to enroll 500 participants. It is not specified if participants will be randomly assigned to different groups.
What's involved
Participants will complete comprehensive assessments, including interviews and behavioral ratings, and receive Cognitive Behavioral Therapy. Repeated assessments will occur throughout the study period, up to 28 weeks.
Compensation
Not stated in the trial record.
Follow-up
Participants will be assessed up to 28 weeks after starting treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07296939

Youth Emotional and Behavioral Treatment Study

Recruiting
NAAges 4–17InterventionalTreatment
Florida State University
~500 participants
Updated 2026-05-14 on ClinicalTrials.gov
What's tested:Cognitive Behavioral Therapy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Clinical Global Impressions - Improvement Scale
Measured over Post-treatment (up to 28 weeks from baseline)
+1 more outcome measured

Conditions

Depression, Anxiety

Explore related trials

AnxietyDepression

Where it's being run

1 sites across 1 states
Florida1

Who to contact

Sherelle Harmon, PhD
[email protected]
18506458724
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Children between the ages of 4-17 years
(a) a principal diagnosis of an anxiety or mood disorder per DSM-5 criteria, OR (b) parent report of clinically impairing irritability, emotional dysregulation, and/or disruptive behavior in youth
Child and parent must be able to complete consent documents, assessments, and participate in treatment in English without a translator
At least one parent must be available and willing to participant in both phases.

Exclusion

Gross neurological, sensory, or motor impairment
History of seizure disorder, psychosis, or organic brain syndrome
Conditions requiring acute intervention, e.g., active suicidality
Non-English speaking child or parent

What this trial measures

  • Clinical Global Impressions - Improvement ScalePost-treatment (up to 28 weeks from baseline)

    Clinician-rated assessment of overall clinical change, with scores ranging from 1 (very much improved) to 7 (very much worse).

  • Affective Reactivity IndexBaseline to post-treatment (up to 28 weeks)

    Youth- and caregiver-reported measure of irritability, with total scores ranging from 0 to 12; higher scores indicate greater symptom severity.